Results 91 to 100 of about 9,532 (171)

Relapsed/refractory multiple myeloma with extramedullary plasmacytomas successfully rechallenged with humanized B-cell maturation antigen-directed chimeric antigen receptor T-cell immunotherapy in an advanced disease stage: A case report. [PDF]

Exp Ther Med
Zhang R, Cheng L, Liu J, Zhang L, Zhuang J.   +4 more
europepmc   +1 more source

A Bioequivalence Study Comparing Two Pomalidomide Hard Capsule Formulations in Healthy Chilean Subjects. [PDF]

Pharmaceuticals (Basel)
Davanço MG, Vespasiano TP, Moisan J, Gonzalez O, Sarmiento M, Groleau M.   +5 more
europepmc   +1 more source

Design, synthesis, and biological activity of novel pomalidomide linked with diphenylcarbamide derivatives

Heterocyclic Communications, 2022
Sun Bin, Liu Xiaofei, Ji Tao, Zhan Xiaoguang, Mao Longfei, Deng Peng, Shi Lin   +6 more
doaj   +1 more source

Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma

, 2013
Multiple myeloma remains an incurable disease despite the introduction of the immunomodulatory drugs (IMiDs) thalidomide and lenalidomide and the proteasome inhibitor bortezomib that have improved the outcome of patients with both newly diagnosed and ...
Terpos, Evangelos, Kanellias, Nikolaos, Christoulas, Dimitrios, Dimopoulos, Meletios A., Dimopoulos, Meletios A, Kastritis, Efstathios   +5 more
core  

Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma. [PDF]

IDCases
Horigome Y, Michishita Y, Tanaka M, Yanagida T, Konishi H, Ehata K, Hayama K, Kamata H, Miyazaki K, Suzuki T.   +9 more
europepmc   +1 more source

Bridging E3 Ligase Binding and Targeted Degradation Through Fluorescence Polarization. [PDF]

Int J Mol Sci
González-Pico L, Camino T, Ortigueira S, Prieto-Díaz R, Sotelo E, Majellaro M.   +5 more
europepmc   +1 more source

Effect of pomalidomide on T cell polarization is mediated through epigenetic modifcations

, 2018
Resumen del póster presentado al 22nd Congress of the European Hematology Association, celebrado en Madrid (España) del 22 al 25 de junio de 2017.-- Alvarez Laderas, Isabel et al.[Background]: There is conflicting evidence regarding the potential use of ...
Pérez Simón, Jose Antonio, Reyes, José C., Ceballos, María L. de, Piruat, José I., Álvarez Laderas, Isabel   +4 more
core  

IMiD-based monotherapy for maintenance of remission in primary CNS lymphoma: a single-center experience. [PDF]

Blood Neoplasia
Randall MP, Tsang M, Gee J, Yung C, Rubenstein JL.   +4 more
europepmc   +1 more source

Pomalidomide [PDF]

, 2020
openaire   +1 more source

GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies. [PDF]

Cancer
Pan D, Kumar A, Lipof JJ, Chung A, Wolf JL, Martin TG, Arora S, Sayre PH, Chari A.   +8 more
europepmc   +1 more source